Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts

J. Espin, M. Schlander, B. Godman, P. Anderson, J. Mestre-Ferrandiz, A. Hutchings, S. Flostrand, A. Parnaby

Research output: Contribution to conferenceAbstract

Abstract

European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

Conference

ConferenceISPOR 20th Annual European Congress
CountryUnited Kingdom
CityGlasgow
Period4/11/178/11/17
Internet address

Fingerprint

Health Expenditures
Pharmaceutical Preparations
Delivery of Health Care
Pressure

Keywords

  • European healthcare
  • healthcare expenditure
  • pharmacoeconomics

Cite this

Espin, J., Schlander, M., Godman, B., Anderson, P., Mestre-Ferrandiz, J., Hutchings, A., ... Parnaby, A. (Accepted/In press). Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.
Espin, J. ; Schlander, M. ; Godman, B. ; Anderson, P. ; Mestre-Ferrandiz, J. ; Hutchings, A. ; Flostrand, S. ; Parnaby, A. / Forecasting pharmaceutical expenditure in Europe : adjusting for the impact of rebates and discounts. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.1 p.
@conference{4f95e10b7ea346be88e6024eaaf0e1c9,
title = "Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts",
abstract = "European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.",
keywords = "European healthcare, healthcare expenditure, pharmacoeconomics",
author = "J. Espin and M. Schlander and B. Godman and P. Anderson and J. Mestre-Ferrandiz and A. Hutchings and S. Flostrand and A. Parnaby",
year = "2017",
month = "8",
day = "7",
language = "English",
note = "ISPOR 20th Annual European Congress ; Conference date: 04-11-2017 Through 08-11-2017",
url = "https://www.ispor.org/Event/index/2017Glasgow",

}

Espin, J, Schlander, M, Godman, B, Anderson, P, Mestre-Ferrandiz, J, Hutchings, A, Flostrand, S & Parnaby, A 2017, 'Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts' ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4/11/17 - 8/11/17, .

Forecasting pharmaceutical expenditure in Europe : adjusting for the impact of rebates and discounts. / Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Hutchings, A.; Flostrand, S.; Parnaby, A.

2017. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Forecasting pharmaceutical expenditure in Europe

T2 - adjusting for the impact of rebates and discounts

AU - Espin, J.

AU - Schlander, M.

AU - Godman, B.

AU - Anderson, P.

AU - Mestre-Ferrandiz, J.

AU - Hutchings, A.

AU - Flostrand, S.

AU - Parnaby, A.

PY - 2017/8/7

Y1 - 2017/8/7

N2 - European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

AB - European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.

KW - European healthcare

KW - healthcare expenditure

KW - pharmacoeconomics

UR - https://www.ispor.org/Event/index/2017Glasgow

M3 - Abstract

ER -

Espin J, Schlander M, Godman B, Anderson P, Mestre-Ferrandiz J, Hutchings A et al. Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts. 2017. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.